Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

rebel distributors corp. - betamethasone valerate (unii: 9ifa5xm7r2) (betamethasone - unii:9842x06q6m) - betamethasone valerate 1 mg in 1 g - betamethasone valerate cream is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. betamethasone valerate cream is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

deseret biologicals, inc. - peumus boldus leaf (unii: q4ewm09m3o) (peumus boldus leaf - unii:q4ewm09m3o), chelidonium majus whole (unii: 7e889u5rnn) (chelidonium majus - unii:7e889u5rnn), smilax ornata whole (unii: sjo6nf5h81) (smilax ornata whole - unii:sjo6nf5h81), gelsemium sempervirens root (unii: 639kr60q1q) (gelsemium sempervirens root - unii:639kr60q1q), veratrum album root (unii: qns6w5us1z) (veratrum album root - unii:qns6w5us1z), beta vulgaris whole (unii: 4g174v5051) (beta vulgaris - unii:4g174v5051), iron (unii: e1uol152h7) (iron - unii:e1uol152h7), iodine (unii: 9679tc07x4) (iodine - unii:9679tc07x4), lycopodium clavatum spore (unii: c88x29y479) (lycopodium clavatum spore - unii:c88x29y479), strychnos nux-vomica seed (unii: 269xh13919) (strychnos nux-vomica seed - unii:269xh13919), pulsatilla pratensis whole (unii: 8e272251di) (pulsatilla pratensis whole - unii:8e272251di), selenium (unii: h6241uj22b) (selenium - unii:h6241uj22b), thuja occidentalis leafy twig (unii: 1nt28v9397) (thuja occidentalis leafy twig - unii:1nt28v9397), zinc (unii: j41csq7qds) (zinc - unii:j41csq7qds) - beta vulgaris – mucus congestion, boldo – occasional constipation, chelidonium majus - perspiration, ferrum metallicum – nasal discomfort, gelsemium sempervirens - expectoration, iodium – mucus congestion, lycopodium clavatum – bladder discomfort, nux vomica – occasional constipation, pulsatilla (pratensis) - perspiration, sarsaparilla (smilax regelii) – nasal discomfort, selenium metallicum - expectoration, thuja occidentalis – mucus congestion, veratrum album – bladder discomfort, zincum metallicum – occasional constipation • for the temporary relief of symptoms including: • bladder discomfort  • perspiration • expectoration • nasal discomfort • mucus congestion • occasional constipation these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

e. fougera & co. a division of fougera pharmaceuticals inc. - betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - betamethasone 0.5 mg in 1 ml - betamethasone dipropionate lotion (augmented), 0.05% is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years of age or older. betamethasone dipropionate lotion (augmented), 0.05% is contraindicated in patients who are hypersensitive to betamethasone dipropionate, to other corticosteroids, or to any ingredient in this preparation. risk summary there are no available data on betamethasone dipropionate lotion (augmented), 0.05% use in pregnant women to identify a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. observational studies suggest an increased risk of low birthweight infants with the use of greater than 300 grams of potent or very potent topical corticosteroid during a pregnancy. advise pregnant women that betamethasone dipropionate lotion (augmented), 0.05% may increase the risk of having a low birthweight infant and to use betamethasone dipropionate lotion

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

oaklock, llc - betamethasone acetate (unii: ti05ao53l7) (betamethasone - unii:9842x06q6m), betamethasone sodium phosphate (unii: 7bk02scl3w) (betamethasone - unii:9842x06q6m) - betamethasone acetate 3 mg in 1 ml - when oral therapy is not feasible, the intramuscular use of betamethasone sodium phosphate and betamethasone acetate injectable suspension is indicated as follows: allergic states control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. dermatologic diseases bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (stevens-johnson syndrome). endocrine disorders congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis. hydrocortisone or cortisone is the drug of choice in primary or secondary adrenocortical insufficiency. synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance. gastrointestinal diseases to tide the patient over a critical period of the disease in regional enteritis and ulcerative colitis. hematologic disorders acquired (autoimmune) hemolytic anemia, diamond-blackfan anemia, pure red cell aplasia, selected cases of secondary thrombocytopenia. miscellaneous trichinosis with neurologic or myocardial involvement, tuberculous meningitis with subarachnoid block or impending block when used with appropriate antituberculous chemotherapy. neoplastic diseases for palliative management of leukemias and lymphomas. nervous system acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor or craniotomy. ophthalmic diseases sympathetic ophthalmia, temporal arteritis, uveitis and ocular inflammatory conditions unresponsive to topical corticosteroids. renal diseases to induce diuresis or remission of proteinuria in idiopathic nephrotic syndrome or that due to lupus erythematosus. respiratory diseases berylliosis, fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy, idiopathic eosinophilic pneumonias, symptomatic sarcoidosis. rheumatic disorders as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis; acute rheumatic carditis; ankylosing spondylitis; psoriatic arthritis; rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy). for the treatment of dermatomyositis, polymyositis, and systemic lupus erythematosus. the intra-articular or soft tissue administration of betamethasone sodium phosphate and betamethasone acetate injectable suspension is indicated as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis, acute and subacute bursitis, acute nonspecific tenosynovitis, epicondylitis, rheumatoid arthritis, synovitis of osteoarthritis. the intralesional administration of betamethasone sodium phosphate and betamethasone acetate injectable suspension is indicated for alopecia areata; discoid lupus erythematosus; keloids; localized hypertrophic, infiltrated, inflammatory lesions of granuloma annulare, lichen planus, lichen simplex chronicus (neurodermatitis), and psoriatic plaques; necrobiosis lipoidica diabeticorum. betamethasone sodium phosphate and betamethasone acetate injectable suspension may also be useful in cystic tumors of an aponeurosis or tendon (ganglia). betamethasone sodium phosphate and betamethasone acetate injectable suspension is contraindicated in patients who are hypersensitive to any components of this product. intramuscular corticosteroid preparations are contraindicated for idiopathic thrombocytopenic purpura.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

remedyrepack inc. - betamethasone acetate (unii: ti05ao53l7) (betamethasone - unii:9842x06q6m), betamethasone sodium phosphate (unii: 7bk02scl3w) (betamethasone - unii:9842x06q6m) - betamethasone acetate 3 mg in 1 ml - when oral therapy is not feasible, the intramuscular use of betamethasone sodium phosphate and betamethasone acetate injectable suspension is indicated as follows: allergic states control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. dermatologic diseases bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (stevens-johnson syndrome). endocrine disorders congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis. hydrocortisone or cortisone is the drug of choice in primary or secondary adrenocortical insufficiency.  synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

deseret biologicals, inc. - magnesium orotate (unii: gi96w46m5a) (magnesium orotate - unii:gi96w46m5a), beta vulgaris (unii: 4g174v5051) (beta vulgaris - unii:4g174v5051), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl), cysteine (unii: k848jz4886) (cysteine - unii:k848jz4886), pulsatilla vulgaris (unii: i76kb35jev) (pulsatilla vulgaris - unii:i76kb35jev), adenine (unii: jac85a2161) (adenine - unii:jac85a2161), amygdalin (unii - magnesium orotate 12 [hp_x] in 1 ml - temporary relief of symptoms related to vitamin b complex in foods and supplements, including upper respiratory, gastrointestinal, urinary and fatigue. temporary relief of symptoms related to vitamin b complex in foods and supplements, including upper respiratory, gastrointestinal, urinary and fatigue.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

deseret biologicals, inc. - magnesium orotate (unii: gi96w46m5a) (magnesium orotate - unii:gi96w46m5a), beta vulgaris (unii: 4g174v5051) (beta vulgaris - unii:4g174v5051), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl), cysteine (unii: k848jz4886) (cysteine - unii:k848jz4886), pulsatilla vulgaris (unii: i76kb35jev) (anemone pulsatilla - unii:i76kb35jev), adenine (unii: jac85a2161) (adenine - unii:jac85a2161), amygdalin (unii: - magnesium orotate 12 [hp_x] in 1 ml - temporary relief of symptoms related to vitamin b complex in foods and supplements, including upper respiratory, gastrointestinal, urinary and fatigue. **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

bioactive nutritional, inc. - alfalfa (unii: djo934brbd) (alfalfa - unii:djo934brbd), avena sativa flowering top (unii: ma9cqj3f7f) (avena sativa flowering top - unii:ma9cqj3f7f), chelidonium majus (unii: 7e889u5rnn) (chelidonium majus - unii:7e889u5rnn), american ginseng (unii: 8w75vcv53q) (american ginseng - unii:8w75vcv53q), beta vulgaris (unii: 4g174v5051) (beta vulgaris - unii:4g174v5051), calendula officinalis flowering top (unii: 18e7415pxq) (calendula officinalis flowering top - unii:18e7415pxq), echinacea angustifolia (un - alfalfa 1 [hp_c] in 1 ml - for temporary relief of fatigue, indigesiton, and flatulent colic. for temporary relief of fatigue, indigesiton, and flatulent colic.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

bioactive nutritional, inc. - alfalfa (unii: djo934brbd) (alfalfa - unii:djo934brbd), american ginseng (unii: 8w75vcv53q) (american ginseng - unii:8w75vcv53q), avena sativa flowering top (unii: ma9cqj3f7f) (avena sativa flowering top - unii:ma9cqj3f7f), beta vulgaris (unii: 4g174v5051) (beta vulgaris - unii:4g174v5051), calendula officinalis flowering top (unii: 18e7415pxq) (calendula officinalis flowering top - unii:18e7415pxq), chelidonium majus (unii: 7e889u5rnn) (chelidonium majus - unii:7e889u5rnn), echinacea angustifolia (un - for temporary relief of fatigue, indigestion, and flatulent colic. for temporary relief of fatigue, indigestion, and flatulent colic.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

bayer healthcare pharmaceuticals inc. - interferon beta-1b (unii: ttd90r31wz) (interferon beta-1b - unii:ttd90r31wz) - interferon beta-1b 0.25 mg in 1 ml - betaseron is indicated for the treatment of relapsing forms of multiple sclerosis (ms), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. betaseron is contraindicated in patients with a history of hypersensitivity to natural or recombinant interferon beta, albumin (human), or any other component of the formulation. although there have been no well-controlled studies in pregnant women, available data, which includes prospective observational studies, have not generally indicated a drug-associated risk of major birth defects with interferon beta-1b during pregnancy. administration of betaseron to monkeys during gestation resulted in increased embryo-fetal death at or above exposures greater than 3 times the human therapeutic dose (see animal data ). in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. the background risk o